Interaction of hyperbaric oxygenation with nifedipine and propranolol at the level of autonomic regulation of the heart in patients with angina pectoris. | Canada Hyperbarics Skip to main content
Clinical Study Kardiologiia 1992

Interaction of hyperbaric oxygenation with nifedipine and propranolol at the level of autonomic regulation of the heart in patients with angina pectoris.

Seriakov VV, Sidorenko BA, Efuni SN — Kardiologiia, 1992

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated how hyperbaric oxygenation, alone or combined with nifedipine or propranolol, affected autonomic cardiac regulation in 33 male patients with coronary heart disease and angina pectoris.

What They Found

In 33 male patients, a single hyperbaric oxygenation session diminished sympathetic activation and increased heart rate caused by nifedipine (n=18) by reducing its central sympathetic effect. When combined with propranolol (n=15), hyperbaric oxygenation further reduced sympathetic activity and its cardiac rhythm effects by potentiating the drug's negative chronotropic action.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

A limitation of this study is its small sample size of 33 male patients and its focus on specific medications from an older era.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Cardiac
Source Pubmed
PubMed ID 1614022
Year Published 1992
Journal Kardiologiia
MeSH Terms Adult; Aged; Angina Pectoris; Combined Modality Therapy; Depression, Chemical; Drug Synergism; Heart; Heart Rate; Humans; Hyperbaric Oxygenation; Male; Middle Aged; Nifedipine; Propranolol; Vagus Nerve

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology